Concepedia

Shirley Kalogeropoulos

SK

Statistics

Publications

3

Citations

143

H-Index

3

Active since

2003

Affiliations

Bristol-Myers Squibb (United States)(Current)

Shirley Kalogeropoulos is an author at Bristol-Myers Squibb (United States) specializing in ligand binding, pharmacology, and cancer pharmacology.

Publications per year

2003–2009

3

Publications

3

Design, Synthesis, and Evaluation of Radiolabeled Integrin α <sub> <i>v</i> </sub> β <sub>3</sub> Receptor Antagonists for Tumor Imaging and Radiotherapy

Thomas D. Harris, Shirley Kalogeropoulos, Tiffany Nguyen et al. · Cancer Biotherapy and Radiopharmaceuticals · 2003 · 82 citations

, , +17

Development of a Multigram Asymmetric Synthesis of 2-(<i>R</i>)-2-(4,7,10-Tris <i>tert</i>-Butylcarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)-pentanedioic Acid, 1-<i>tert</i>-Butyl Ester, (<i>R</i>)-<i>tert</i>-Bu<sub>4</sub>-DOTAGA

Stuart G. Levy, Vincent Jacques, Kevin Li Zhou et al. · Organic Process Research & Development · 2009 · 33 citations

, , +10

Structure−Activity Relationships of <sup>111</sup>In- and <sup>99m</sup>Tc-Labeled Quinolin-4-one Peptidomimetics as Ligands for the Vitronectin Receptor:  Potential Tumor Imaging Agents

Thomas D. Harris, Shirley Kalogeropoulos, Tiffany Nguyen et al. · Bioconjugate Chemistry · 2006 · 28 citations

, , +16

1–3 of 3